Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
Journal of Clinical Pharmacy and Therapeutics|August 26, 2018
Identification of risk factors and development of detection algorithm for denosumab-induced hypocalcaemiaTakuya Imatoh, Kimie Sai, Mayu Takeyama, et al.
The Journal of Rheumatology|May 17, 2019
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung DiseaseTomoyuki Fujisawa, Hironao Hozumi, Hideki Yasui, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 19, 2020
Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infectionMasanori Harada, Kazuki Furuhashi, Masato Karayama, et al.
Respiratory Investigation|September 24, 2022
Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physiciansTakafumi Koyauchi, Yuzo Suzuki, Yusuke Inoue, et al.
Annals of the American Thoracic Society|September 30, 2016
Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary TuberculosisYuzo Suzuki, Masahiro Shirai, Kazuhiro Asada, et al.
Medical Oncology (Northwood, London, England)|September 7, 2018
Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysisMasato Karayama, Naoki Inui, Kazuki Tanaka, et al.
Respiratory Medicine Case Reports|November 26, 2025
Massive immune-related myositis and cytokine release syndrome during dual immunotherapy plus chemotherapy for recurrent lung adenocarcinoma: case reportShogo Nakai, Yusuke Inoue, Masato Karayama, et al.
Lung Cancer (Amsterdam, Netherlands)|November 27, 2024
Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational studyMasato Karayama, Takafumi Suda, Kiyotaka Yoh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2021
Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab TherapyMasato Karayama, Yusuke Inoue, Katsuhiro Yoshimura, et al.
Respiratory Medicine Case Reports|March 21, 2022
Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case reportYasutaka Mochizuka, Tomoyuki Fujisawa, Yusuke Inoue, et al.
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
Journal of Clinical Pharmacy and Therapeutics|August 26, 2018
Identification of risk factors and development of detection algorithm for denosumab-induced hypocalcaemiaTakuya Imatoh, Kimie Sai, Mayu Takeyama, et al.
The Journal of Rheumatology|May 17, 2019
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung DiseaseTomoyuki Fujisawa, Hironao Hozumi, Hideki Yasui, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 19, 2020
Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infectionMasanori Harada, Kazuki Furuhashi, Masato Karayama, et al.
Respiratory Investigation|September 24, 2022
Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physiciansTakafumi Koyauchi, Yuzo Suzuki, Yusuke Inoue, et al.
Annals of the American Thoracic Society|September 30, 2016
Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary TuberculosisYuzo Suzuki, Masahiro Shirai, Kazuhiro Asada, et al.
Medical Oncology (Northwood, London, England)|September 7, 2018
Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysisMasato Karayama, Naoki Inui, Kazuki Tanaka, et al.
Respiratory Medicine Case Reports|November 26, 2025
Massive immune-related myositis and cytokine release syndrome during dual immunotherapy plus chemotherapy for recurrent lung adenocarcinoma: case reportShogo Nakai, Yusuke Inoue, Masato Karayama, et al.
Lung Cancer (Amsterdam, Netherlands)|November 27, 2024
Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational studyMasato Karayama, Takafumi Suda, Kiyotaka Yoh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2021
Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab TherapyMasato Karayama, Yusuke Inoue, Katsuhiro Yoshimura, et al.
Respiratory Medicine Case Reports|March 21, 2022
Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case reportYasutaka Mochizuka, Tomoyuki Fujisawa, Yusuke Inoue, et al.
Pageof 20